Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,208 | -13,141 | -9,867 | -5,045 | -13,882 |
| Depreciation Amortization | 167 | 161 | 107 | 52 | 231 |
| Accounts receivable | 1 | 47 | N/A | N/A | 28 |
| Accounts payable and accrued liabilities | 1,090 | 512 | 1,146 | 293 | 55 |
| Other Working Capital | 1,037 | 1,056 | 1,515 | 420 | 8 |
| Other Operating Activity | 14 | 321 | -523 | 2 | 728 |
| Operating Cash Flow | $-15,899 | $-11,044 | $-7,622 | $-4,278 | $-12,832 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | N/A | N/A | N/A | -221 |
| Investing Cash Flow | $-13 | $N/A | $N/A | $N/A | $-221 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 25,750 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -3,228 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $22,522 |
| Exchange Rate Effect | 204 | -95 | 182 | 236 | 499 |
| Beginning Cash Position | 19,784 | 19,769 | 19,783 | 19,783 | 9,816 |
| End Cash Position | 4,076 | 8,630 | 12,343 | 15,741 | 19,784 |
| Net Cash Flow | $-15,708 | $-11,139 | $-7,440 | $-4,042 | $9,968 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,899 | -11,044 | -7,622 | -4,278 | -12,832 |
| Capital Expenditure | -13 | N/A | N/A | N/A | -221 |
| Free Cash Flow | -15,912 | -11,044 | -7,622 | -4,278 | -13,053 |